Navigation Links
IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare
Date:4/2/2008

BOSTON, April 2, 2008 /PRNewswire/ -- IC Sciences Corporation announced today the launch of the company's alliance membership program, ICS Alliance (http://www.icsciencesalliance.com). During the past two years, IC Sciences has been developing components for the newly launched membership program, such as scientific tools, industry products, and market case studies covering healthcare informatics instruments for professional, consumer, and therapeutics medical market sectors. The Alliance program serves as a collaborative nexus of clinicians, healthcare executives, allied professionals, researchers, developers, and other users of these instruments.

Alliance members receive value through a range of program offerings, consisting of a leadership network of experts (Event Series), strategic market analysis and research reports, digital intelligence briefings, and a members-only virtual portal community. Peter M. Nicholas Jr., Founder and Chief Executive Officer of IC Sciences, remarked, "We envision the ICS Alliance as a 'central exchange station' of multi-perspective and multi-sector ideas, tools, practices, and contacts concerning healthcare informatics. We are pleased to be in our second year of the Event Series, which has hosted 18 events and has featured guest hosts such as Clayton Christensen of Harvard Business School, Jonathan Bush of AthenaHealth, and Charlie Baker of Harvard Pilgrim Health. We look forward to inviting the nation's e-health executives, clinicians, and medical informatics leaders to join our membership in 2008 and beyond."

Alliance members, who currently include Revolution Health, AthenaHealth, PatientsLikeMe, and Blue Cross Blue Shield of Massachusetts, joined the program because of a collective interest in understanding this rapidly evolving field, as well as how new sciences and technologies are improving the effectiveness, value, and experience of healthcare. These informatics instruments are used by clinicians, patients, consumers, payers, and therapeutics manufacturers in myriad contexts and applications, including patient engagement, collective intelligence among clinician or patient peers, clinical performance management, and therapeutic product support.

To learn more about ICS Alliance and membership benefits and opportunities, visit http://www.icsciencesalliance.com.

About IC Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. IC Sciences Corporation, through its operating companies, is creating the world's most comprehensive and broadly based developer of intelligent informatics systems and digital informatics instruments for the professional, consumer, and therapeutics medical markets. Our core business is about employing the Internet and related technology platforms to support the delivery of informed clinical systems that optimally impact patient care through the science and the art of contextually differentiated informing. For more information, please visit: http://www.ICSciences.com

Contact:

IC Sciences Corporation

One Joy Street Boston, MA 02108

publicrelations@icsciences.com

1-800-603-1420


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
11. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental ... samples to full-size tissues, bones, even whole organs to implant in people to ... blood deep into the developing tissue. , Current bioengineering techniques, including 3-D ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... March 22, 2017 Oramed Pharmaceuticals Inc. ... www.oramed.com ), a clinical-stage pharmaceutical ... delivery systems, announced today that Dr. Miriam ... a presentation titled, "Oral Insulin for Diabetes Treatment: ... Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... 22, 2017 The global chronic ... research report by Transparency Market Research (TMR). The top ... and AbbVie Inc., accounted for a share of only ... in this market are focusing aggressively on mergers, acquisitions, ... is likely to lead to market consolidation in the ...
Breaking Biology Technology:
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
Breaking Biology News(10 mins):